Covered recipient · General Payments record
SEEMA ABDULHAMID MISBAH
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$9,488.62
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $4,565.00 | 1 |
| Consulting Fee | $1,200.00 | 2 |
| Food and Beverage | $706.53 | 8 |
| Grant | $350.00 | 1 |
| Education | $99.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novocure Inc. | $4,565.00 | 1 |
| Acerta Pharma LLC | $988.08 | 3 |
| BeiGene USA, Inc. | $675.00 | 1 |
| Incyte Corporation | $224.99 | 2 |
| SOBI, INC | $122.87 | 1 |
| GlaxoSmithKline, LLC. | $120.83 | 1 |
| Tempus AI, Inc | $106.89 | 2 |
| TAIHO ONCOLOGY, INC. | $103.81 | 1 |
| Celgene Corporation | $14.05 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $350.00 | 01/03/2024 | Grant | Undisputed | 01/23/2026 | 1105633130 | CMS |
| AstraZeneca Pharmaceuticals LP | $525.00 | 08/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105662284 | CMS |
| AstraZeneca Pharmaceuticals LP | $113.08 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126677486 | CMS |
| BeiGene USA, Inc. | $675.00 | 11/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120854715 | CMS |
| Celgene Corporation | $14.05 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101116548 | CMS |
| GlaxoSmithKline, LLC. | $120.83 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115731869 | CMS |
| Incyte Corporation | $125.00 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141247522 | CMS |
| Incyte Corporation | $99.99 | 12/17/2024 | Education | Undisputed | 01/23/2026 | 1141171497 | CMS |
| Novocure Inc. | $4,565.00 | 01/05/2024 | Honoraria | Undisputed | 01/23/2026 | 1119257958 | CMS |
| SOBI, INC | $122.87 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141430413 | CMS |
| TAIHO ONCOLOGY, INC. | $103.81 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137943953 | CMS |
| Tempus AI, Inc | $20.89 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150170040 | CMS |
| Tempus AI, Inc | $86.00 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150170042 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.